| Literature DB >> 26900152 |
Valérie Guillet1, Ségolène Galandrin2, Laurent Maveyraud2, Simon Ladevèze2, Vincent Mariaule2, Cécile Bon2, Nathalie Eynard2, Mamadou Daffé2, Hedia Marrakchi3, Lionel Mourey4.
Abstract
Mycolic acids are essential components of the mycobacterial cell envelope, and their biosynthetic pathway is one of the targets of first-line antituberculous drugs. This pathway contains a number of potential targets, including some that have been identified only recently and have yet to be explored. One such target, FadD32, is required for activation of the long meromycolic chain and is essential for mycobacterial growth. We report here an in-depth biochemical, biophysical, and structural characterization of four FadD32 orthologs, including the very homologous enzymes fromMycobacterium tuberculosisandMycobacterium marinum Determination of the structures of two complexes with alkyl adenylate inhibitors has provided direct information, with unprecedented detail, about the active site of the enzyme and the associated hydrophobic tunnel, shedding new light on structure-function relationships and inhibition mechanisms by alkyl adenylates and diarylated coumarins. This work should pave the way for the rational design of inhibitors of FadD32, a highly promising drug target.Entities:
Keywords: crystal structure; drug design; enzyme inhibitor; fatty acyl ACP-synthase; fatty acyl-AMP ligase; mycobacteria; tuberculosis
Mesh:
Substances:
Year: 2016 PMID: 26900152 PMCID: PMC4825004 DOI: 10.1074/jbc.M115.712612
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157